AmbioPharm
Manufacturing · South Carolina, United States · 600 Employees
View Company Info for Free
About
Headquarters
1024 Dittman Ct, North Augusta, South Carolina,...Phone Number
(803) 442-7590Website
www.ambiopharm.comRevenue
$202.5 MillionIndustry
Recent News & Media
Highlights
-
Total Funding Amount
-
Most Recent Funding Amount
1
Number of Funding Rounds
Who is AmbioPharm
AmbioPharm, Inc. (APi) is a full-service peptide manufacturing company headquartered in North Augusta, South Carolina.
Popular SearchesAmbiopharm IncAmbiopharmAmbio IncAmbio Holdings IncAmbioPharm - A Global Peptide CDMOSIC Code 28,283NAICS Code 32,325Show more
AmbioPharm Org Chart
Similar Companies to AmbioPharm
704$101.3M1
- 850$300M
2
- 547$90.9M
3
- 553$196.7M
4
- 224$142.3M
5
- 146$31.8M
6
AmbioPharm Company Metrics
Funding
Funding DateAug 08, 2018
RoundPrivate Equity
Amount-
InvestorsThe Carlyle Group
See More
-
Total Funding Amount
-
Most Recent Funding Amount
1
Number of Funding Rounds
AmbioPharm Tech Stack
A closer look at the technologies used by AmbioPharm
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
AmbioPharm News & Media
AmbioPharm Appoints Industry Veteran Brian Gregg as CEO
NORTH AUGUSTA, S.C.--(BUSINESS WIRE)-- #cGMP--AmbioPharm, a worldwide leader in peptide active pharmaceutical ingredient (API) contract development and manufacturing organization (CDMO) services, announced the appointment of industry veteran Brian Gregg as Chief Executive Officer, today. Mr. Gregg, who has more than 30 years of experience in the peptide CDMO industry, succeeds Tim Nieters, who will be stepping down after 7 years with the company. Mr. Gregg joins AmbioPharm following a 32-year caOct 2, 2023BioStock: CombiGene welcomes AmbioPharm as CDMO in pain project
CombiGene has entered into a partnership with AmbioPharm, a US-based contract manufacturer for the COZY01 peptide-based pain project, jointly undertaken with Zyneyro. With extensive experience in peptide development and manufacturing, AmbioPharm meets all regulatory criteria, setting the stage for toxicology studies and human studies. AmbioPharm's ability for commercial production also positions them as a potential long-term partner in the COZY01 venture. Read the article at biostock.se: https:/Sep 19, 2023AmbioPharm, a Global Peptide CDMO
SHANGHAI--(BUSINESS WIRE)-- #cGMP--AmbioPharm, a worldwide leader in peptide API CDMO services, continues growth to meet capacity demands for late phase and commercial peptide production. A reliable peptide CDMO with manufacturing facilities both in China and the USA, AmbioPharm is ready to meet the needs of a global market. AmbioPharm Shanghai Campus The latest addition to the AmbioPharm Shanghai campus brings a total of approximately 380,550 ft2 (35,354 m2) of manufacturing and administrativeJul 26, 2023AmbioPharm Provides an Update on South Carolina Headquarters Expansion
NORTH AUGUSTA, S.C.--(BUSINESS WIRE)-- #CDMO--AmbioPharm, a worldwide leader in peptide API CDMO services, continues growth to meet capacity demands for late phase and commercial peptide production while increasing our sustainability efforts. In order to meet customer needs, we continue to make state-of-the-art upgrades to our AmbioPharm South Carolina headquarters, including increasing synthesis capacity at this location. In order to accommodate and support growth in late phase and commercial pMay 17, 2023AmbioPharm Provides an Update on Shanghai Campus Expansion and Resumption of Customer Visits
NORTH AUGUSTA, S.C. & SHANGHAI--(BUSINESS WIRE)-- #cGMP--AmbioPharm Inc., a worldwide leader in peptide API CDMO services, continues growth to meet capacity demands for late phase and commercial peptide production. The latest addition to the AmbioPharm Shanghai campus1,2 brings a total of approximately 380,550 square feet of manufacturing and administrative space. The ongoing expansion to the Shanghai campus includes reactors as large as 5,000 liters and additional purification suites, includingApr 25, 2023
Read more news
Frequently Asked Questions regarding AmbioPharm
AmbioPharm, Inc. (APi) is a full-service peptide manufacturing company headquartered in North Augusta, South Carolina.... Read More
